Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Mayo Clinic National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00830557 |
RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future.
PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.
Condition | Intervention |
---|---|
Islet Cell Tumor Pancreatic Cancer |
Other: medical chart review Other: survey administration Procedure: study of high risk factors |
Study Type: | Observational |
Official Title: | Biospecimen Resource for Pancreas Research, a Data & Tissue Bank (Also Known as a Bio-Repository, Bio-Bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease |
Estimated Enrollment: | 5000 |
Study Start Date: | October 2000 |
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a multicenter study.
Patients complete two 1-hour surveys assessing health, clinical and family history of pancreatic conditions including cancer, and food preparation and intake. Patients also complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health practices, and family history. A review of the patient's medical information is obtained from the medical record.
Blood samples are collected for future research studies. Oral cells and stool samples may also be collected for future studies.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Diagnosis or suspicion of at least one of the following:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, Minnesota | |
Mayo Clinic Cancer Center | Recruiting |
Rochester, Minnesota, United States, 55905 | |
Contact: Clinical Trials Office - All Mayo Clinic Locations 507-538-7623 |
Principal Investigator: | Gloria M. Petersen, PhD | Mayo Clinic |
Study ID Numbers: | CDR0000613100, MAYO-35406 |
Study First Received: | January 27, 2009 |
Last Updated: | February 6, 2009 |
ClinicalTrials.gov Identifier: | NCT00830557 History of Changes |
Health Authority: | Unspecified |
recurrent pancreatic cancer stage I pancreatic cancer stage II pancreatic cancer stage III pancreatic cancer stage IV pancreatic cancer |
recurrent islet cell carcinoma pancreatic alpha cell carcinoma pancreatic beta islet cell carcinoma pancreatic delta cell carcinoma pancreatic G-cell carcinoma |
Pancreatic Islet Cell Tumors Digestive System Neoplasms Pancreatic Neoplasms Carcinoma, Islet Cell Endocrine System Diseases Adenoma, Islet Cell Pancrelipase Recurrence |
Carcinoma Digestive System Diseases Pancreatic Diseases Gastrointestinal Neoplasms Endocrinopathy Adenoma Endocrine Gland Neoplasms Neoplasms, Glandular and Epithelial |
Neoplasms Neoplasms by Histologic Type Digestive System Diseases Neoplasms by Site Digestive System Neoplasms Pancreatic Neoplasms |
Endocrine System Diseases Pancreatic Diseases Adenoma, Islet Cell Adenoma Neoplasms, Glandular and Epithelial Endocrine Gland Neoplasms |